|
⚲
|
| Keyboard |
| Nagendran Sukumar
✚
|
|
|---|---|
| CIK # | 0001665124 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001665124] | |
| 4 | [0001665124] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nagendran Sukumar | |
| Solid Biosciences Inc | |
| Taysha Gene Therapies Inc | |
| Health Sciences Acquisitions Corp | |
| AveXis Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2026-01-26 | Sell | 26,918 | $4.61 | 124,092 |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2026-01-23 | Sell | 89,132 | $4.75 | 423,377 |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2026-01-12 | Sell | 200,000 | $4.71 | 942,000 |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2026-01-12 | Grant | 427,000 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Employee Stock Option (right to buy) · derivative
|
2026-01-12 | Grant | 274,000 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2026-01-12 | Option exercise | 88,676 | $1.71 | 151,636 |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2026-01-12 | Option exercise | 111,324 | $0.70 | 77,927 |
|
Taysha Gene Therapies Inc TSHA
Employee Stock Option (right to buy) · derivative
|
2026-01-12 | Option exercise | 111,324 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Employee Stock Option (right to buy) · derivative
|
2026-01-12 | Option exercise | 88,676 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Employee Stock Option (right to buy) · derivative
|
2025-12-01 | Option exercise | 260,047 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2025-12-01 | Option exercise | 260,047 | $1.71 | 444,680 |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2025-12-01 | Sell | 260,047 | $4.51 | 1,172,812 |
|
Taysha Gene Therapies Inc TSHA
Employee Stock Option (right to buy) · derivative
|
2025-11-28 | Option exercise | 70,172 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2025-11-28 | Sell | 110,125 | $4.75 | 523,094 |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2025-11-28 | Option exercise | 39,953 | $1.71 | 68,320 |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2025-11-28 | Option exercise | 70,172 | $0.70 | 49,120 |
|
Taysha Gene Therapies Inc TSHA
Employee Stock Option (right to buy) · derivative
|
2025-11-28 | Option exercise | 39,953 | $0.00 | |
|
Solid Biosciences Inc SLDB
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 77,500 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Common Stock
|
2025-01-02 | Grant | 324,500 | $0.00 | |
|
Taysha Gene Therapies Inc TSHA
Employee Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 324,500 | $0.00 | |
| showing 20 of 119 most recent transactions | |||||